Australia markets closed
  • ICL Announces First Quarter 2021 Earnings Call
    Business Wire

    ICL Announces First Quarter 2021 Earnings Call

    ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals and specialty chemicals company, today announced it plans to release first quarter 2021 results prior to the opening of the TASE market on Thursday, May 6, 2021.

  • Worldwide Generic Drugs Industry to 2026 - Players Include Mylan, Novartis and Pfizer Among Others

    Worldwide Generic Drugs Industry to 2026 - Players Include Mylan, Novartis and Pfizer Among Others

    Dublin, April 15, 2021 (GLOBE NEWSWIRE) -- The "Generic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to's offering. The global generic drugs market reached a value of US$ 386 Billion in 2020. A generic drug is a medicine that contains the same active ingredient and has an equivalent therapeutic effect as the branded drug. It is also identical in terms of safety, quality, dosage, strength, route of administration, intended use, effect, form, quality and side effects. These medications can be produced only after the patent expiration of the brand-name drug. As compared to branded drugs, the production of generics costs much less as it does not require the repetition of clinical (human) and animal studies to demonstrate the effectiveness and safety of the medicine. Due to a reduction in the upfront cost of research, generics are typically sold at a substantially lower price in the market.Market Trends:Due to an aging population and increasing incidences of chronic diseases, governments of developed countries have been making efforts to reduce healthcare costs by promoting the production of generics. Whereas, in developing countries, affordability and accessibility are some of the primary issues faced by the healthcare industry. To address these problems, governments and other regulatory bodies have been encouraging manufacturers to introduce effective generic drugs. However, despite the rapid patent expiry of branded drugs, there has been a shortage of generics. This situation is currently being rectified by various initiatives taken by hospitals, institutions and other organizations across the globe. For instance, in 2018, a coalition of seven hospitals and three philanthropies in the US announced that they would be addressing drug shortages and the high cost of essential medications by launching a generic drug company, named Civica Rx. The company is producing 14 short-supply, FDA-approved drugs that have been available in the market since the beginning of 2019. Other than this, in 2018, the United States Food and Drug Administration (USFDA) created policies to make the process of market entry and generic approval more efficient. It issued guidance documents for the development of both hard-to-copy drug categories and specific complex drugs. Looking forward, the publisher expects the global generic drugs market to exhibit moderate growth during the next five years.Breakup by Therapy Area: Central Nervous SystemCardiovascularDermatologyGenitourinary/HormonalRespiratoryRheumatologyDiabetesOncologyOthers Cardiovascular diseases (CVDs) are the leading therapy area, accounting for the majority of the total market, on account of the increasing cases of CVDs as a result of unhealthy eating habits and sedentary lifestyles.Breakup by Drug Delivery: OralInjectablesDermal/TopicalInhalers Currently, oral medicines are the most preferred product, owing to the convenience attached to their administration, which requires minimal to no medical assistance.Breakup by Distribution Channel: Retail PharmaciesHospital Pharmacies At present, the majority of the generics are distributed through retail pharmacy stores as most generic drugs are over the counter (OTC) medicines that can be bought without a prescription.Regional Insights: United StatesChinaBrazilGermanyFranceIndiaUnited KingdomJapanCanadaItalyOthers On a regional basis, the United States represents the biggest market, accounting for the largest market share. This growth is led by numerous initiatives by the US Government to improve generic drug manufacturing and access in the country.Competitive Landscape:The market is fragmented in nature with the presence of various small and large manufacturers. Some of the leading players operating in the market include Teva Pharmaceuticals Industries Ltd., Mylan N.V., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Fresenius SE & Co., Lupin Limited, Endo Pharmaceuticals Inc., Aurobindo Pharma Limited, and Aspen Pharmacare Holdings Limited.Key Questions Answered in This Report: How has the market performed so far and how will it perform in the coming years?What are the key regional markets?What has been the impact of COVID-19 on the global generic drugs market?What are the major drug delivery segments?What are the key therapy areas?What are the major distribution channels?What are the various stages in the value chain of the industry?What are the key driving factors and challenges in the industry?What is the structure of the industry and who are the key players?What is the degree of competition in the industry?What are the profit margins in the industry?What are the key requirements for setting up a manufacturing plant?How are generic drugs manufactured?What are the various unit operations involved in a manufacturing plant?What is the total size of land required for setting up a manufacturing plant?What are the machinery requirements for setting up a manufacturing plant?What are the raw material requirements for setting up a manufacturing plant?What are the packaging requirements for generic drugs?What are the transportation requirements for generic drugs?What are the utility requirements for setting up a manufacturing plant?What are the manpower requirements for setting up a manufacturing plant?What are the infrastructure costs for setting up a manufacturing plant?What are the capital costs for setting up a manufacturing plant?What are the operating costs for setting up a manufacturing plant?What will be the income and expenditures for a manufacturing plant?What is the time required to break-even? Key Topics Covered: 1 Preface2 Scope and Methodology2.1 Objectives of the Study2.2 Stakeholders2.3 Data Sources2.3.1 Primary Sources2.3.2 Secondary Sources2.4 Market Estimation2.4.1 Bottom-Up Approach2.4.2 Top-Down Approach2.5 Forecasting Methodology3 Executive Summary4 Introduction4.1 Overview4.2 Key Industry Trends5 Global Generic Drugs Industry5.1 Market Overview5.2 Market Performance 5.3 Impact of COVID-195.4 Market Breakup by Country5.5 Market Breakup by Therapy Area5.6 Market Breakup by Drug Delivery5.7 Market Breakup by Distribution Channel5.8 Market Forecast 5.9 SWOT Analysis5.9.1 Overview5.9.2 Strengths5.9.3 Weaknesses5.9.4 Opportunities5.9.5 Threats5.10 Value Chain Analysis5.10.1 Research and Development5.10.2 Manufacturing5.10.3 Marketing and Distribution5.11 Porter's Five Forces Analysis5.11.1 Overview5.11.2 Bargaining Power of Buyers5.11.3 Bargaining Power of Suppliers5.11.4 Degree of Competition5.11.5 Threat of New Entrants5.11.6 Threat of Substitutes5.12 Regulations in the Generic Industry5.13 Key Market Drivers and Success Factors6 Performance of Key Countries6.1 United States6.1.1 Market Trends6.1.2 Market Forecast6.2 China6.2.1 Market Trends6.2.2 Market Forecast6.3 Brazil6.3.1 Market Trends6.3.2 Market Forecast6.4 Germany6.4.1 Market Trends6.4.2 Market Forecast6.5 France6.5.1 Market Trends6.5.2 Market Forecast6.6 India6.6.1 Market Trends6.6.2 Market Forecast6.7 United Kingdom6.7.1 Market Trends6.7.2 Market Forecast6.8 Japan6.8.1 Market Trends6.8.2 Market Forecast6.9 Canada6.9.1 Market Trends6.9.2 Market Forecast6.10 Italy6.10.1 Market Trends6.10.2 Market Forecast6.11 Others6.11.1 Market Trends6.11.2 Market Forecast7 Market Breakup by Therapy Area7.1 Central Nervous System7.1.1 Market Trends7.1.2 Market Forecast7.2 Cardiovascular7.2.1 Market Trends7.2.2 Market Forecast7.3 Dermatology7.3.1 Market Trends7.3.2 Market Forecast7.4 Genitourinary/Hormonal7.4.1 Market Trends7.4.2 Market Forecast 7.5 Respiratory7.5.1 Market Trends7.5.2 Market Forecast 7.6 Rheumatology 7.6.1 Market Trends7.6.2 Market Forecast 7.7 Diabetes7.7.1 Market Trends7.7.2 Market Forecast7.8 Oncology7.8.1 Market Trends7.8.2 Market Forecast7.9 Others7.9.1 Market Trends7.9.2 Market Forecast8 Market Breakup by Drug Delivery8.1 Oral8.1.1 Market Trends8.1.2 Market Forecast8.2 Injectables 8.2.1 Market Trends8.2.2 Market Forecast8.3 Dermal/Topical8.3.1 Market Trends8.3.2 Market Forecast8.4 Inhalers8.4.1 Market Trends8.4.2 Market Forecast9 Market Breakup by Distribution Channel9.1 Retail Pharmacies9.1.1 Market Trends9.1.2 Market Forecast9.2 Hospital Pharmacies9.2.1 Market Trends9.2.2 Market Forecast10 Competitive Landscape10.1 Competitive Structure10.2 Market Breakup by Key Players10.3 Key Player Profiles10.3.1 Teva Pharmaceuticals Industries Ltd.10.3.2 Mylan N.V.10.3.3 Novartis AG10.3.4 Pfizer Inc.10.3.5 Sun Pharmaceutical Industries Ltd.10.3.6 Fresenius SE & Co.10.3.7 Lupin Limited10.3.8 Endo Pharmaceuticals Inc.10.3.9 Aurobindo Pharma Limited10.3.10 Aspen Pharmacare Holdings Limited11 Generic Drugs Manufacturing Process11.1 Product Overview11.2 Detailed Process Flow (Tablets)11.3 Detailed Process Flow (Injectable)11.4 Various Types of Unit Operations Involved11.5 Mass Balance and Raw Material Requirements12 Project Details, Requirements and Costs Involved12.1 Land Requirements and Expenditures12.2 Construction Requirements and Expenditures12.3 Plant Machinery12.4 Machinery Pictures12.5 Raw Material Requirements and Expenditures12.6 Packaging Requirements and Expenditures12.7 Transportation Requirements and Expenditures12.8 Utility Requirements and Expenditures12.9 Manpower Requirements and Expenditures12.10 Other Capital Investments13 Loans and Financial Assistance14 Project Economics14.1 Capital Cost of the Project14.2 Techno-Economic Parameters14.3 Product Pricing and Margins Across Various Levels of the Supply Chain14.4 Taxation and Depreciation14.5 Income Projections14.6 Expenditure Projections14.7 Financial Analysis14.8 Profit Analysis For more information about this report visit CONTACT: CONTACT: Laura Wood, Senior Press Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

  • FreeCast's SelectTV Offers Outdoor Channel, Sportsman Channel, and World Fishing Network
    PR Newswire

    FreeCast's SelectTV Offers Outdoor Channel, Sportsman Channel, and World Fishing Network

    SelectTV customers are enjoying three top-rated outdoor lifestyle channels—Outdoor Channel, Sportsman Channel and World Fishing Network—as part of the Value TV bundle, a low-cost, high-value package of top-tier channels for the SelectTV audience.